APA (7th ed.) Citation

Bauer, K. I., Baker, D., Lerner, R., Koeck, T., Buch, G., Fischer, Z., . . . Araldi, E. (2025). Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: Results from the EmDia clinical trial. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02916-0

Chicago Style (17th ed.) Citation

Bauer, Katrin I., et al. "Effect of Empagliflozin on the Plasma Lipidome in Patients with Type 2 Diabetes Mellitus: Results from the EmDia Clinical Trial." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02916-0.

MLA (9th ed.) Citation

Bauer, Katrin I., et al. "Effect of Empagliflozin on the Plasma Lipidome in Patients with Type 2 Diabetes Mellitus: Results from the EmDia Clinical Trial." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02916-0.